Literature DB >> 32357434

Erratum: Berndsen, R.H., et al. Colorectal Cancer Growth Retardation through Induction of Apoptosis, Using an Optimized Synergistic Cocktail of Axitinib, Erlotinib, and Dasatinib, Cancers 2019, 11, 1878.

Robert H Berndsen1,2, Nathalie Swier2, Judy R van Beijnum2, Patrycja Nowak-Sliwinska1,3.   

Abstract

The authors wish to make the following corrections to this paper[...].

Entities:  

Year:  2020        PMID: 32357434      PMCID: PMC7281540          DOI: 10.3390/cancers12051079

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


The authors wish to make the following corrections to this paper [1]: The authors apologize for not giving sufficient credit to the involvement of Prof. C.R. Jimenez and her research group in this paper. Therefore, the following section is corrected: The “Acknowledgements” statement should be changed to: Acknowledgements: The authors acknowledge Marloes Zoetemelk for the preparation of RNAseq material and Tse Wong for the expert technical support. The authors thank the iGE3 Genomics Platform (UNIGE) for preforming RNAseq experiments. The authors acknowledge Connie R. Jimenez and her team (Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands and OncoProteomics Laboratory, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands) for generating the phosphoproteomics data included in Figure 3. The authors would like to apologize for any inconvenience caused to the readers by these changes.
  1 in total

1.  Colorectal Cancer Growth Retardation through Induction of Apoptosis, Using an Optimized Synergistic Cocktail of Axitinib, Erlotinib, and Dasatinib.

Authors:  Robert H Berndsen; Nathalie Swier; Judy R van Beijnum; Patrycja Nowak-Sliwinska
Journal:  Cancers (Basel)       Date:  2019-11-27       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.